Rigel Pharma Cash Flow - Annual (NASDAQ:RIGL)

Add to My Stocks
$3.59 $0.07 (1.99%) RIGL stock closing price Sep 19, 2018 (Closing)

For analyzing any company like Rigel Pharma from an investment perspective, its important to check the cash flow statement. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Rigel Pharma profits one has to check the income statement and for Rigel Pharma debt one has to check the balance sheet. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Rigel Pharma stock analysis. Rigel Pharma generated $-77.55M cash from operating activities in 2017. RIGL decrease in investments stood at a value of $-19.47M for the latest year 2017.

View details of Rigel Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-77.99M-69.21M-51.46M-90.9M-89.02M-98.84M-85.97M37.89M-111.54M-132.34M
Depreciation Depletion Amortization Cash-Flow-1.05M1.43M2.35M2.59M2.43M1.95M1.31M1.4M1.42M
Net Increase (Decrease) in Assets Liabilities-5.43M-15.79M19.26M-0.19M-6.79M-1.4M1.47M-8.9M-6.07M3.64M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net5.75M8.06M7.34M18.99M7.16M12.61M13.16M16.43M13.43M23.75M
Net Cash from (used by) Operating Activities
-77.55M-75.88M-23.41M-69.75M-86.06M-85.19M-69.37M46.74M-102.77M-103.51M
Increase (Decrease) in Prop Plant And Equipment--0.71M-0.48M-0.17M-1.22M-3.37M-2.3M-3.56M-0.12M-2.48M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-20.04M25.59M45.09M63.11M73.6M-35.67M-60.54M-49.84M-30.53M-24.48M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
-19.47M24.88M44.61M62.93M72.38M-39.05M-62.84M-53.4M-30.66M-26.97M
Issuance (Purchase) of Equity Shares117.68M25.18M7.05M1.17M1.05M139.09M142.77M1.96M103.6M130.37M
Issuance (Repayment) of Debt Securities-------0.8M-1.14M-1.44M1.61M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
117.68M25.18M7.05M1.17M1.05M139.09M141.97M-102.15M131.99M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
20.65M-25.82M28.25M-5.65M-12.63M14.85M9.75M-5.84M-31.28M1.5M
Cash & Equivalents at Beginning of Year17.63M43.45M15.2M20.85M33.48M18.63M8.87M14.71M46M44.5M
Cash & Equivalents at Year End38.29M17.63M43.45M15.2M20.85M33.48M18.63M8.87M14.71M46M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Rigel Pharma stock price history and Rigel Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Rigel Pharma has cash of $38.29M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Rigel Pharma stock price.
  • The cash generated from the core business or operations was a negative at $-77.55M for Rigel Pharma in the latest 2017. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-19.47M for RIGL stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $117.68M for Rigel Pharma.

Key Financial Ratios For Rigel Pharma Cash Flow